CE Marked medical device peel within the Enerpeel range manufactured in the European Union
Manufactured under GMP and ISO 13485 Compliant quality management systems for medical devices
Part of the Enerpeel professional chemoexfoliation system for aesthetic medicine and dermatology
CE Marked medical device peel within the Enerpeel range manufactured in the European Union
Manufactured under GMP and ISO 13485 Compliant quality management systems for medical devices
Part of the Enerpeel professional chemoexfoliation system for aesthetic medicine and dermatology
Salicylic acid chest and back peel for acne
Description
Enerpeel SA-CB Chest & Back is a specialised medical salicylic acid chemical peel formulated in the patented Enerpeel carrier system specifically for the treatment of comedonic and inflammatory acne on the chest and/or back. It combines 30% salicylic acid with the OSK acne-complex actives triethyl citrate, ethyl linoleate and GT-peptide-10 to control sebum, bacterial activity, inflammation and hyperkeratinisation within the pilosebaceous unit. The Enerpeel carrier delivers these actives deeply into acne-prone body areas while minimising surface irritation, so redness and downtime are reduced compared with conventional salicylic peels. Each professional pack from Fillers Direct contains 8 x 5 ml vials for in-clinic use.
Bnefits
Dedicated protocol for treating comedonic and inflammatory acne on the chest and back
30% salicylic acid provides strong sebostatic, comedolytic and keratolytic action in acne-prone skin
Triethyl citrate and ethyl linoleate help inhibit bacterial lipases, reduce sebum and modulate inflammation
GT-peptide-10 supports anti-inflammatory and reparative processes in acne lesions
Targets the four main visible signs of acne (comedones, papules, pustules and oiliness) on large chest and back areas
Patented Enerpeel carrier restrains surface activity then drives actives into the pilosebaceous unit, reducing surface erythema and visible peeling
Medical protocol reported to kill a high percentage of acne bacteria, including antibiotic-resistant strains, when combined with corresponding homecare
Average application time before removal/neutralisation is a few minutes, with relatively limited downtime for a body peel
Can be integrated into comprehensive acne management plans alongside Enerpeel SA for the face and OSK-based homecare products
Indications
Comedonic and inflammatory acne on the chest
Comedonic and inflammatory acne on the back
Oily and seborrhoeic skin on chest and back with enlarged or blocked follicles
Follicular congestion and body breakouts linked to hormonal or seborrhoeic tendencies
Post-acne textural irregularities and blemishes on chest and back as part of a broader acne protocol
Excipients suitable for topical chemoexfoliation (medical-device formulation)
Formulation
Liquid salicylic acid peel formulated in the Enerpeel carrier technology for enhanced, uniform penetration
Active acid concentration: 30% salicylic acid providing strong keratolytic and sebostatic effects
Incorporates triethyl citrate, ethyl linoleate and GT-peptide-10 (OSK complex) to reduce sebum output, inhibit acne-related bacterial activity and control inflammation
Enerpeel carrier restrains proton activity at the skin surface before accelerating penetration into deeper follicular structures, reducing surface trauma and erythema
Chemoexfoliation depth: very superficial to superficial for trunk skin, with a focus on the pilosebaceous unit within chest and back areas
Designed as a medical protocol for use on limited large areas (e.g. chest or back per session) due to 30% salicylic acid concentration
Packaging
Box containing 8 x 5 ml vials of Enerpeel SA-CB Chest & Back solution
Each 5 ml vial provides sufficient product for treating the chest or the back in a single session, depending on body size and protocol
Professional-use presentation for in-clinic application only
Typically used in conjunction with Enerpeel preparatory products and Enerpeel Neutraliser wipes/solution as part of the complete system
Usage
For professional in-clinic use only by trained medical or aesthetic practitioners.
Take a complete medical and dermatological history and assess acne severity, skin type and risk of post-inflammatory hyperpigmentation.
Cleanse the chest or back thoroughly to remove surface oils, sweat and debris.
Degrease and prepare the skin according to Enerpeel protocol, commonly using an appropriate pre-peel solution or wipe.
Protect highly sensitive or non-target areas (e.g. areolae, any open lesions, fresh scars) with barrier products as per clinic protocol.
Open one 5 ml vial of Enerpeel SA-CB and pour into a sterile dish or use directly with the supplied applicator/brush.
Apply a uniform layer of the peel over the acne-affected area of the chest or back using a brush or applicator, avoiding mucous membranes and broken skin.
Allow the peel to act for several minutes (typically around 3–7 minutes), monitoring patient comfort and clinical endpoints such as erythema and visible salicylate crystallisation on the surface.
At the end of the prescribed exposure time, or earlier if indicated by patient discomfort or skin response, neutralise/remove the peel according to Enerpeel protocol—usually by wiping with Enerpeel Neutraliser wipes or solution and/or with damp cotton pads to remove precipitated salicylic acid.
After removal/neutralisation, gently pat dry and apply soothing, hydrating and barrier-supportive post-peel products as recommended, followed by broad-spectrum sunscreen on any exposed areas.
Advise the patient to avoid excessive heat, friction and UV exposure on the treated areas for several days and to follow a recommended OSK-based homecare regimen to maintain results.
Do not treat multiple large body areas with 30% salicylic acid in a single session; for safety, limit each peel to chest or back or another single region as per manufacturer recommendations.
Contraindications
Known hypersensitivity or allergy to salicylic acid, triethyl citrate, ethyl linoleate, GT-peptide-10 or any component of the Enerpeel SA-CB formulation.
Active skin infections, open wounds, widespread eczema, psoriasis or severe dermatitis in the intended treatment area.
Extensive sunburn or significant irritation of the chest or back at the time of proposed treatment.
Recent ablative procedures, deep peels or other resurfacing treatments on the same area where healing is incomplete.
History of keloid or hypertrophic scarring or impaired wound healing, unless carefully assessed and monitored by a medical professional.
Current or very recent systemic isotretinoin therapy, where strong chemical peels on large body areas are generally contraindicated (follow local guidelines).
Pregnancy or breastfeeding as a precaution, unless the supervising physician explicitly approves treatment in line with local regulations.
Very dark Fitzpatrick skin types at high risk of post-inflammatory hyperpigmentation unless treated by an experienced clinician under strict protocols.
Patients unable or unwilling to adhere to post-peel instructions, particularly avoidance of scratching and adherence to appropriate body photoprotection.
Adverse Effects
Transient warmth, burning or stinging sensations during application, usually subsiding after removal/neutralisation.
Temporary erythema, dryness, tightness and mild flaking or superficial peeling of the treated chest or back skin over subsequent days.
Formation of a white, powdery salicylic precipitate on the skin surface during treatment, which is expected and removed at the end of exposure.
Risk of post-inflammatory hyperpigmentation or hypopigmentation, particularly in darker skin types or if post-procedure sun exposure occurs without adequate protection.
Less commonly, more persistent erythema, oedema or irritation which may require topical treatment and modification of subsequent peel parameters.
Rarely, blistering, erosions, secondary infection or scarring if protocols are exceeded, contraindications ignored or aftercare is inadequate.
Possible allergic or idiosyncratic reactions to salicylic acid, the OSK actives, the carrier solution or associated pre-/post-peel products.
Storage Conditions
Store in a cool, dry place away from direct sunlight and heat sources.
Keep vials in their original packaging and tightly closed until use to prevent evaporation or degradation.
Observe any specific storage temperature recommendations in the Enerpeel SA-CB instructions for use (typically controlled room temperature unless otherwise specified).
Do not use after the expiry date printed on the packaging.
Keep out of reach of children and non-professional users.
Duration
Enerpeel SA-CB is typically used within a course of several treatments (for example, 3\u20134 peels) performed at intervals of around 2\u20133 weeks, depending on acne severity, skin response and clinical protocol. Each in-clinic peel session involves a contact time of a few minutes (approximately 3\u20137 minutes) before removal/neutralisation. Maintenance courses can be repeated as needed, guided by clinical outcomes and patient tolerance.
Onset
Initial improvements in oiliness and inflammatory lesion activity on the chest and back are often visible within the first one or two sessions, while more substantial clearing of acne, reduction in congestion and improvement in texture typically develop progressively over the full course of treatments and consolidate in the weeks following the last peel, especially when combined with appropriate homecare and photoprotection.
